Myosin 18B is a member of the myosin superfamily, proteins that are highly specialized for various cellular functions, including muscle contraction, cell motility, and maintenance of cell shape. Myosin 18B, in particular, plays a unique role in the organization of the cytoskeleton, contributing to the structural integrity of cells and possibly influencing the formation of cell-to-cell contacts. Unlike the classical myosins that are primarily involved in muscle contraction, Myosin 18B is thought to serve more nuanced roles in the cellular architecture and signaling. The regulation of Myosin 18B expression is a complex process involving a myriad of cellular signals and transcriptional networks. Understanding the factors that can induce the expression of Myosin 18B could provide insights into the fundamental aspects of cell biology and the intricate dance of protein interactions that underpin cellular structure and function.
Several chemicals have been identified that can potentially act as activators to induce the expression of Myosin 18B. These activators range from naturally occurring compounds to synthetic molecules, each influencing the cellular machinery in distinct ways. For instance, retinoic acid, found in vitamin A, can bind to nuclear receptors and initiate a transcriptional cascade that may include the upregulation of Myosin 18B. Forskolin, another activator, works by increasing intracellular cAMP levels, which can trigger a signaling pathway leading to the induction of Myosin 18B expression. Compounds such as Trichostatin A and sodium butyrate play their role through epigenetic modifications; they inhibit histone deacetylases, leading to a more relaxed chromatin structure that allows gene transcription to proceed, potentially increasing the levels of Myosin 18B. These activators, along with others such as lithium chloride and beta-estradiol, act on diverse points of the cellular signaling pathways, highlighting the complexity of gene expression regulation. The study of these activators and their interaction with cellular processes is not only fascinating for its biological implications but also crucial for expanding our knowledge of the genetic control mechanisms that govern protein expression.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid might bind directly to retinoic acid receptors, which can initiate transcription and potentially stimulate the upregulation of Myosin 18B by activating gene promoters associated with muscle development. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferases, 5-Azacytidine could cause hypomethylation of the Myosin 18B gene promoter, leading to its increased transcription in muscle cells. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
This compound has the potential to enhance the acetylation of histones surrounding the Myosin 18B gene, thereby promoting an open chromatin configuration and subsequent transcriptional activation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin may elevate intracellular cAMP, which in turn could activate protein kinase A (PKA) and lead to the phosphorylation of transcription factors that stimulate Myosin 18B expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
By activating protein kinase C, phorbol esters could trigger a signal transduction cascade that culminates in the enhanced transcription of the Myosin 18B gene. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can inhibit GSK-3, potentially leading to the nuclear accumulation and activation of β-catenin, which might upregulate Myosin 18B gene transcription. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
Through binding to its cognate estrogen receptors, β-Estradiol could initiate a transcriptional program that includes the upregulation of genes such as Myosin 18B in estrogen-responsive tissues. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone may bind glucocorticoid receptors, leading to the recruitment of coactivators to the Myosin 18B gene promoter, which can increase its transcriptional activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin Gallate could stimulate antioxidant response elements within the promoter regions of certain genes, potentially leading to the increased expression of Myosin 18B through transcription factor Nrf2 activation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate, as a HDAC inhibitor, could promote histone hyperacetylation at the Myosin 18B locus, thereby enhancing the accessibility of transcription machinery and stimulating gene expression. |